Protective effect of non-mitogenic human acidic fibroblast growth factor on hepatocyte injury

Hepatology Research

Volumn 37, Issue 10, 2007, Pages 836-844

  Xu, Hua ^a,c   Hai, Guang Fan ^b   Xiang, Ji Zhou ^c   Yao, Cheng Can ^a   Zheng, Qing ^a   Zhang, Qi Hao ^a   Hong, Hai ^d  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Xinxiang College   (China)

^c UNIVERSITY OF JINAN   (China)

^d SUN YAT SEN UNIVERSITY   (China)

Author keywords

CCl4; H2O2; Hepatic protection; Hepatocyte; Non mitogenic human acidic fibroblast growth factor

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE; LIVER PROTECTIVE AGENT; NONMITOGENIC HUMAN ACIDIC FIBROBLAST GROWTH FACTOR; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL INFILTRATION; CELL SWELLING; CELL VACUOLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DNA DETERMINATION; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG MEGADOSE; ELECTROPHORESIS; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; INFLAMMATORY CELL; LIVER CELL; LIVER CELL DAMAGE; LIVER PROTECTION; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 34548147783     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00131.x     Document Type: Article

References (21)

1. Cuevas P, Carceller F, Lozano RM et al. Protection of rat myocardium by mitogenic and non-mitogenic fibroblast growth factor during post-ischemic reperfusion. Growth Factors 1997; 15: 29-40.
2. Lozano RM, Pineda-Lucena A, Gonzalez C et al. 1 H NMR structural characterization of a non-mitogenic, vasodilatory, ischemia-protector and neuromodulatory acidic fibroblast growth factor. Biochemistry 2000; 39: 4982-3.
3. Cuevas P, Carceller F, Lozano RM et al. Non-mitogenic form of the FGF1 was equally protective. Growth Factors 1997; 15: 29-40.
4. Fu X, Cuevas P, Gimenez-Gallego G. The effects of fibroblast growth factors on ischemic kidney, liver and gut injuries. Chin Med J (Engl) 1998; 111: 398-403.
5. Gu JY, Mei J, Huang SD et al. Improvement of cardiac function after adenovirus mediated gene transfer of acidic fibroblast growth factor to chronic ischemic myocardium in swine. Med J Chin PLA 2002; 27: 979-80.
6. Yu C, Wang F, Jin C et al. Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis. Am J Pathol 2003; 163: 1653-62.
7. Cronauer MV, Schulz WA, Seifert HH et al. Fibroblast growth factor and their receptors in urological cancers: Basic research and clinical implications. Eur Urol 2003; 43: 309-19.
8. Wu XP, Su ZJ, Li XK et al. High-level expression and purification of a non-mitogenic form of human acidic fibroblast growth factor in Escherichia coli. Protein Expr Purif 2005; 42: 7-11.
9. Zheng Q, Wang XF, Wu XP et al. The mitogenic activity decline of a haFGF mutant and its mechanism. Chin J Pathophysiol 2005; 21: 446-4.
10. Zheng Q, Zhan M, Xu H et al. The effect of nm-aFGF on SOD and MDA and NO after retinal ischemia-reperfusion injury. Shandong Med 2005; 45: 15-16.
11. Hu SF, Huang JE, Li XK et al. Protective effects of non-mitogen acidic fibroblast growth factor on injuries of carotid sinus. Anat Res 2003; 25: 175-7.
12. Weng LX, Fu XB, Li XX et al. The effects of the modified and the wild-type aFGF on the hepatic and renal function after guts' ischemia reperfusion. Chin Crit Care Med 2004; 16: 19-21.
13. Gao F, Deng XM, An TZ, Liu ZX, Pan YQ. Acidic fibroblast growth factor correlates with tumor growth. Chin J Vet Sci 2002; 22: 260-1.
14. Lin ZF, Li XK, Lin Y et al. Protective effects of non-mitogenic human acidic fibroblast growth factor on hydrogen peroxide-induced damage to cardiomyocytes in vitro. World J Gastroenterol 2005; 11: 5492-7.
15. De Zwart LL, Meerman JHN, Commandeur JNM et al. Biomarkers of free radical damage applications in experimental animals and in humans. Free Rad Biol Med 1999; 26: 202-26.
16. Recknagel RO, Glendek EAJ, Dolakk JA et al. Mechanisms of carbon tetrachloride toxicity. Pharmacol Ther 1989; 43: 139-54.
17. Basu S. Carbon tetrachloride-induced lipid peroxidation: Icosanoid formation and their regulation by antioxidant nutrients [J]. Toxicology 2003; 189: 113-27.
18. Jialan S, Kenichi A, Yoji I et al. Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride. Am J Pathol 1998; 153: 515-25.
19. Cao DG, Li XK, Fu XB et al. Effect of modified acidic fibroblast growth factor thymocyte apoptosis induced by dexamethasone in mouse. J China Biotechnol 2003; 23: 80-4.
20. Fu XB, Li XK, Wang T et al. Enhanced anti-apoptosis and gut epithelium protection function of acidic fibroblast growth factor after canceling of its mitogenic activity. World J Gastroenterol 2004; 10: 3590-6.
21. Xu H, Yang JN, Zheng Q. et al. The protection of non-mitogenic recombinant human acidic fibroblast growth factor on the rat retina injury induced by MNU. Acta Pharmaceutica Sinica 2005; 40: 306-10.